In partnership with Newcastle Hospitals and University College London, we are supporting the evaluation of Kromek’s low-dose molecular breast imaging technology.

Breast screening in women aged 50-70…

Diagnostics North East (DxNE), a consortium of the North East of England’s leading Diagnostics organisations, are excited to announce that registration is now open for our annual conference.

The theme…

In collaboration with the Academic Health Science Network for the North East and North Cumbria, we have produced an overview of near-patient tests for cholesterol.

Heart and…

We are excited to share that Capital Enterprise, the P4SY Accelerator Programme, and their headline sponsors, Scarborough Group International, will be hosting the first P4SY Showcase & MedTech Conference…

We are supporting the UK based company AlphaBiomics with their test to personalise treatment for Inflammatory Bowel Disease.

Inflammatory bowel disease (IBD) affects around 1 in 100 people across the…

Cancer Research UK are holding their next Innovation Summit in Newcastle upon Tyne on 26 May.

This free, in-person, all day event is aimed at early career…

We have successfully applied for over £120,000 from the National Institute for Health and Care Research to help refine the diagnosis of depression and bipolar disorder.

Mental health problems are…

Recently Diagnostics North East hosted a virtual conference to showcase the unique expertise available within the network for diagnostic developers.

Over 180 individuals attended the Diagnostics North…

We are helping GlycoScoreDx Ltd. to commercialise their diagnostic test for improved detection of prostate cancer.

Every 45 minutes one man dies of prostate cancer in the UK. Developing better…

We are part of Diagnostics North East (DxNE), a network of organisations which helps the diagnostics sector. We are excited to share that the next DxNE…

Using a standardised approach to diagnose chronic lymphocytic leukaemia should enable patients to have earlier access to treatments and help NHS laboratories.

As the population ages, more people are developing…

Since it has been implemented the new testing strategy for Familial Hypercholesterolaemia has saved patient lives and the NHS money.

Familial Hypercholesterolaemia (FH) is a common inherited condition affecting around…